| scholarly article | Q13442814 |
| P50 | author | Elizabeth Barrett-Connor | Q37322423 |
| Diabetes Prevention Program Research Group | Q47171583 | ||
| Xavier Pi-Sunyer | Q62994897 | ||
| Abbas E Kitabchi | Q62995074 | ||
| P2093 | author name string | Catherine Kim | |
| Frankie B Stentz | |||
| Bin Nan | |||
| Shengchun Kong | |||
| Mary Beth Murphy | |||
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| Lifestyle changes in women with polycystic ovary syndrome | Q24234000 | ||
| Sex hormone-binding globulin and risk of type 2 diabetes in women and men | Q24643947 | ||
| Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial | Q32014763 | ||
| Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. | Q33770352 | ||
| Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women | Q33942448 | ||
| Estrogen and progesterone exposure is reduced in response to energy deficiency in women aged 25-40 years | Q34071156 | ||
| Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation | Q34175422 | ||
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin | Q34335548 | ||
| Relationships of circulating sex hormone-binding globulin with metabolic traits in humans | Q34355301 | ||
| Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis | Q34502187 | ||
| Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies | Q35287715 | ||
| Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women | Q35432866 | ||
| Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program | Q36134744 | ||
| Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation | Q36201486 | ||
| Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP). | Q36477804 | ||
| Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions | Q37061253 | ||
| The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women | Q37417467 | ||
| The optimal timing of blood collection during the menstrual cycle for the assessment of endogenous sex hormones: can interindividual differences in levels over the whole cycle be assessed on a single day? | Q40663661 | ||
| Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease | Q42472403 | ||
| Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises | Q43637162 | ||
| The control of the interaction of sex hormone-binding globulin with its receptor by steroid hormones | Q43732475 | ||
| Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study | Q43843236 | ||
| Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status | Q44392844 | ||
| Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. | Q44834990 | ||
| Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial | Q44846663 | ||
| Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. | Q46140757 | ||
| Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations | Q46162472 | ||
| Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome | Q46609404 | ||
| Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. | Q51494027 | ||
| Racial differences in premenopausal endogenous hormones. | Q51510601 | ||
| Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. | Q51554374 | ||
| Dynamics of serum testosterone during the menstrual cycle evaluated by daily measurements with an ID-LC-MS/MS method and a 2nd generation automated immunoassay. | Q53108990 | ||
| Polycystic Ovary Syndrome | Q56092373 | ||
| The effect of endurance training on the relationships between sex hormone binding globulin, high density lipoprotein cholesterol, apoprotein A1 and physical fitness in pre-menopausal women with mild obesity | Q72091077 | ||
| Racial differences in the correlation between gonadal androgens and serum insulin levels | Q78238461 | ||
| Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women | Q79182457 | ||
| Postmenopausal sex hormones in relation to body fat distribution | Q83222329 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3049-3057 | |
| P577 | publication date | 2013-05-24 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program | |
| P478 | volume | 98 |
| Q27023901 | Endogenous sex hormones, metabolic syndrome, and diabetes in men and women |
| Q92049271 | Is menopause still evolving? Evidence from a longitudinal study of multiethnic populations and its relevance to women's health |
| Q92676368 | Lifestyle changes in women with polycystic ovary syndrome |
| Q35837589 | Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome |
| Q37715543 | Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus |
Search more.